|
|
|
|
Abbott to Pay $1.67B in Patent Suit
At issue was whether or not Abbotts anti-tumor necrosis factor arthritis drug Humira infringed on J&Js blockbuster Remicade, co-owned by New York University and marketed by J&Js bio arm Centocor.Like Remicade, Humira is a fully...
|
|
|
FDA Panel Calls for Ban on Narcotic/Tylenol Combo Drugs
A joint committee of three FDA advisory groups voted on Tuesday to recommend the elimination of prescription combination drugs containing acetaminophen due to a spike in instances of liver-induced toxicity.The panel of experts, physicians...
|
|
|
Finding the Perfect Pharma Match
According to a joint press release issued on June 1, this is the first time two large pharma companies have come together at such an early stage of a drug's development.The deal is that they share the Phase I costs to test the...
|
|
|
'Pharmerging' Markets And The New World Order
Collectively, these seven countries - Brazil, Mexico, China, India, Russia, Turkey, South Korea - are predicted to enjoy a CAGR of 1316% by 2013.Very healthy figures, and perhaps not totally surprising, but they prompted David Campbell,...
|
|
|
GSK Says Asia Pacific Sales Could Double
'Clearly there will be a very high demand in the future because the economic development of the countries in the region and people want more healthcare,' Christophe Weber, GSK Asia Pacific chief, told Reuters.GSK Says Asia Pacific Sales...
|
|
|
New EU Committee Leaves Member States Out In The Cold
The ostensibly bland context for this row is the otherwise unremarkable proposal to put some more muscle into monitoring pharmaceuticals on the market.The proposal is the least controversial element in the 'pharma package' now inching its...
|
|
|
European Approval for UCB's Cimzia
UCB said that the drug will be made available in the Europe before the end of the year and is now only awaiting marketing authorisation from the EU.European Approval for UCB's Cimzia.
|
|
|
Building a Better Brief Summary
FDA wanted to find out what people really think of the risk information printed on the back of pharmaceutical advertising.Surprise, people are tend to absorb far less information from the giant blocks of text printed in drab language.
|
|
|
Live from DIA: Bridging the Data Gap
At the Drug Information Associations annual meeting, Pharm Exec got a few minutes to talk with a little software company named Microsofts about its work in creating integration between electronic data capture [EDC] and electronic health...
|
|
|
Working Towards a Solution : An Interview with Oracles Neil de Crescenzo
Just a few days shy of the one year anniversary of the launch of Oracles Health Sciences Global Business Unit, Neil de Crescenzo, senior vice president and general manager for the business unit sat down with Pharm Exec to talk about the...
|
